CM

Charles A. McWherter

CT Cymabay Therapeutics: 32 patents #1 of 38Top 3%
MT Monsanto Technology: 5 patents #640 of 1,728Top 40%
DC Diatex Co.: 4 patents #1 of 25Top 4%
PH Pharmacia: 2 patents #167 of 528Top 35%
GS G.D. Searle: 1 patents #415 of 659Top 65%
ME Metabolex: 1 patents #34 of 50Top 70%
📍 Oakland, CA: #77 of 4,380 inventorsTop 2%
🗺 California: #9,798 of 386,348 inventorsTop 3%
Overall (All Time): #67,645 of 4,157,543Top 2%
44
Patents All Time

Issued Patents All Time

Showing 1–25 of 44 patents

Patent #TitleCo-InventorsDate
11596614 Treatment of intrahepatic cholestatic diseases Pol Boudes 2023-03-07
11406611 Treatment of intrahepatic cholestatic diseases Pol Boudes 2022-08-09
11224580 Treatment of intrahepatic cholestatic diseases Pol Boudes 2022-01-18
11179359 Treatment of NAFLD and NASH Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin 2021-11-23
11000494 Treatment of intrahepatic cholestatic diseases Pol Boudes 2021-05-11
10828273 Treatment of intrahepatic cholestatic diseases Pol Boudes 2020-11-10
10813895 Treatment of intrahepatic cholestatic diseases Pol Boudes 2020-10-27
10813896 Treatment of intrahepatic cholestatic diseases Pol Boudes 2020-10-27
10722483 Treatment of NAFLD and NASH Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin 2020-07-28
10512622 Treatment of intrahepatic cholestatic diseases Pol Boudes 2019-12-24
10478411 Treatment of intrahepatic cholestatic diseases Pol Boudes 2019-11-19
10342770 Treatment of NAFLD and NASH Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin 2019-07-09
10292983 Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions 2019-05-21
10272058 Treatment of intrahepatic cholestatic diseases Pol Boudes 2019-04-30
10220011 Treatment of intrahepatic cholestatic diseases Pol Boudes 2019-03-05
10188620 Treatment for NAFLD and NASH Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin 2019-01-29
10137112 Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Brian K. Roberts, Gopal Chandra Saha, Brian Edward Lavan 2018-11-27
10098843 Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine Robert Martin, David Karpf, Brian K. Roberts, Douglas Alan Lorenz, Rodney James Ketner 2018-10-16
9962346 Treatment of NAFLD and NASH Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin 2018-05-08
9808436 Treatment of intrahepatic cholestatic diseases Pol Boudes 2017-11-07
9801860 Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Brian K. Roberts, Gopal Chandra Saha, Brian Edward Lavan 2017-10-31
9616039 Treatment of NAFLD and NASH Brian K. Roberts, Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin 2017-04-11
9486428 Treatment of intrahepatic cholestatic diseases Pol Boudes 2016-11-08
9439891 Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Brian K. Roberts, Gopal Chandra Saha, Brian Edward Lavan 2016-09-13
9433612 Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Brian K. Roberts, Gopal Chandra Saha, Brian Edward Lavan 2016-09-06